Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study

Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study

Objectives: To quantify mortality rates for patients successfully treated for hepatitis C in the era of interferon-free, direct acting antivirals and compare these rates with those of the general population. Design: Population based cohort study. Setting: British Columbia, Scotland, and England (Eng...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Hamill, V, Wong, S, Benselin, J, Krajden, M, Hayes, PC, Mutimer, D, Yu, A, Dillon, JF, Gelson, W, Velásquez García, HA, Yeung, A, Johnson, P, Barclay, ST, Alvarez, M, Toyoda, H, Agarwal, K, Fraser, A, Bartlett, S, Aldersley, M, Bathgate, A, Binka, M, Richardson, P, Morling, JR, Ryder, SD, Barnes, E
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	British Medical Journal Publishing Group 2023

Míreanna comhchosúla

Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured HCV infection
de réir: Hamish Innes, et al.
Foilsithe / Cruthaithe: (2021-12-01)

Long Term Follow-Up of Patients with Chronic Hepatitis C Treated with Alpha Interferon
de réir: Jane D Collier, et al.
Foilsithe / Cruthaithe: (2000-01-01)

Interferon Status and Choice of Interferons Inducers in Frequently Ill Children
de réir: M. S. Savenkovа, et al.
Foilsithe / Cruthaithe: (2016-06-01)

Publicly Funded, Pegylated Interferon-Alpha Treatment in British Columbia: Disparities in Treatment Patterns for People with Hepatitis C
de réir: Priscilla C Hsu, et al.
Foilsithe / Cruthaithe: (2008-01-01)

My Critique is Bigger than Yours: Constituting Exclusions in Critical Security Studies
de réir: David Roger Mutimer
Foilsithe / Cruthaithe: (2009-10-01)

My Critique is Bigger than Yours: Constituting Exclusions in Critical Security Studies
de réir: David Roger Mutimer
Foilsithe / Cruthaithe: (2009-10-01)

Interferons and autoimmunity.
de réir: Feldmann, M, et al.
Foilsithe / Cruthaithe: (1987)

The expression of interferon-stimulated genes (interferon “signature”) in patients with rheumatoid arthritis (Preliminary results)
de réir: A. S. Avdeeva, et al.
Foilsithe / Cruthaithe: (2021-01-01)

Anti-interferon alpha autoantibodies and their significance in COVID-19
de réir: S. S. Petrikov, et al.
Foilsithe / Cruthaithe: (2022-05-01)

Opposing roles for interferon regulatory factor-3 (IRF-3) and type I interferon signaling during plague.
de réir: Ami A Patel, et al.
Foilsithe / Cruthaithe: (2012-01-01)

Retreatment with Pegylated Interferon Alpha-2a and Ribavirin in Patients with Chronic Hepatitis C Who Have Relapsed or Not Responded to a First Course of Pegylated Interferon-Based Therapy
de réir: Eric M Yoshida, et al.
Foilsithe / Cruthaithe: (2009-01-01)

Type I Interferon Receptor on NK Cells Negatively Regulates Interferon-γ Production
de réir: Amanda J. Lee, et al.
Foilsithe / Cruthaithe: (2019-06-01)

Hormone therapy affecting interferon defense in children with infectious mononucleosis
de réir: I. M. Fedorova, et al.
Foilsithe / Cruthaithe: (2021-11-01)

The Use of Interferon Inducers in an Infectious Disease Clinic
de réir: A. A. Shuldyakov, et al.
Foilsithe / Cruthaithe: (2020-05-01)

Targeted mass spectrometry reveals interferon-dependent eicosanoid and fatty acid alterations in chronic myeloid leukaemia
de réir: Scott, HC, et al.
Foilsithe / Cruthaithe: (2023)

Preuve sérologique de la présence d’anticorps contre <em>Brucella</em> chez les petits ruminants à Sainte-Croix, Iles Vierges américaines
de réir: A.S. Ahl, et al.
Foilsithe / Cruthaithe: (1993-01-01)

Adjuvant therapy of melanoma with interferon: lessons of the past decade
de réir: Kirkwood John M, et al.
Foilsithe / Cruthaithe: (2008-10-01)

Virus Infections and Interferon Inductors in the Complex Therapy
de réir: M. G. Romantsov, et al.
Foilsithe / Cruthaithe: (2020-05-01)

Induction of Type 1, 2 and 3 Interferons by Acridone Acetates
de réir: S. S. Grigoryan, et al.
Foilsithe / Cruthaithe: (2020-05-01)

Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis.
de réir: Cheung, M, et al.
Foilsithe / Cruthaithe: (2016)

Interferon-Gamma: Treatment Horizons
de réir: A. A. Khryanin, et al.
Foilsithe / Cruthaithe: (2020-05-01)

INTERFERONS AND EYE DISEASES
de réir: N. A. Kikhtenko, et al.
Foilsithe / Cruthaithe: (2019-06-01)

The effect of antituberculosis treatment on interferon-γ release assay results
de réir: M. Bugiani, et al.
Foilsithe / Cruthaithe: (2015-12-01)

Screening for hepatocellular carcinoma: patient selection and perspectives
de réir: Fateen W, et al.
Foilsithe / Cruthaithe: (2017-05-01)

THEORETICAL AND APPLIED ASPECTS OF THE INTERFERON SYSTEM: TO THE 60TH ANNIVERSARY OF THE DISCOVERY OF INTERFERONS
de réir: F. I. Ershov, et al.
Foilsithe / Cruthaithe: (2018-02-01)

Differential expression of interferon-gamma and interferon-gamma-inducing cytokines in Thai patients with scrub typhus or leptospirosis.
de réir: Chierakul, W, et al.
Foilsithe / Cruthaithe: (2004)

Interferon-alpha therapy for refractory idiopathic thrombocytopenic purpura in children
de réir: M A Yeşilipek, et al.
Foilsithe / Cruthaithe: (1997-04-01)

Interferon-γ: biological function and application for study of cellular immune response
de réir: A. A. Lutckii, et al.
Foilsithe / Cruthaithe: (2016-02-01)

The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era
de réir: Sonya A MacParland, et al.
Foilsithe / Cruthaithe: (2014-01-01)

ADVERSE EVENTS OF INTERFERONS WITH SYSTEMIC EFFECT
de réir: A. A. Toporov, et al.
Foilsithe / Cruthaithe: (2018-02-01)

Interferon-γ and tumor growth
de réir: A. L. Ilyushin, et al.
Foilsithe / Cruthaithe: (2023-09-01)

Shared and Unique Features of Human Interferon-Beta and Interferon-Alpha Subtypes
de réir: Megen C. Wittling, et al.
Foilsithe / Cruthaithe: (2021-01-01)

Aspects of a Methodological Approach to Determination of Interferon Alpha Specific Activity
de réir: M. L. Baykova, et al.
Foilsithe / Cruthaithe: (2020-03-01)

Altered interferon defense in children with dynamically changed infectious mononucleosis
de réir: E. A. Kukushkina, et al.
Foilsithe / Cruthaithe: (2021-02-01)

Studies on the replication of Mayaro virus grown in interferon treated cells
de réir: M. C. S. Rebello, et al.
Foilsithe / Cruthaithe: (1994-12-01)

Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis
de réir: Foster, G, et al.
Foilsithe / Cruthaithe: (2016)

Efficacy and safety of the new drug against multiple sclerosis «PEGylated Interferon beta-1a Human» in monkeys compared with unmodified interferon beta-1a
de réir: N. A. Spirina, et al.
Foilsithe / Cruthaithe: (2018-02-01)

Efficiency of interferon therapy in patients with essential thrombocythemia or polycythemia vera
de réir: M A Sokolova, et al.
Foilsithe / Cruthaithe: (2016-12-01)

Enhancement of interferon treatment for large basaliomas
de réir: A. V. Molochkov, et al.
Foilsithe / Cruthaithe: (2017-08-01)

Activation of interferon-α signaling by resveratrol, genistein and quercetin
de réir: O. A. Vlasova, et al.
Foilsithe / Cruthaithe: (2019-02-01)